News
UNC Startup Receives Federal Grant to Kick-Start Cancer Research Commercialization
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
UNC Team Discovers Promising Target for New Pancreatic Cancer Treatments
Cell signaling protein may hold key to blocking long-studied genetic mutation
Drug That Inhibits Vascular Development Does Not Help Colon Cancer Survival
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
NCCU and UNC Lineberger Receive NCI Partnership Grant
$11.9 Million in awards to address cancer disparities
National Charity Tennis Event to Benefit UNC Lineberger Comprehensive Cancer Center
N.C. native John Isner and doubles partner Sam Querrey to host
